ENSG vs PHG vs CHE Stock Comparison

Ensign, Koninklijke Philips and Chemed Prices as of Nov 3, 2026 Peers: Industry group
1 more company in this comparison (AVAH) Create a free account to keep reading and compare up to 10 companies.
ENSG Ensign Group, Inc
$182.21 +6.1% 1M -0.9% 1Y
Market cap
$10.92B
P/E
27.3x
Revenue (TTM)
$5.67B
Div. yield
–
Home Health and Senior Care Healthcare
2 wins
PHG Koninklijke Philips Nv
$28.47 +19.0% 1M +4.6% 1Y
Market cap
$29.42B
P/E
15.4x
Revenue (TTM)
$30.13B
Div. yield
–
Diagnostic Equipment Healthcare
6 wins
CHE Chemed Corp
$533.15 +5.1% 1M +21.0% 1Y
Market cap
$7.23B
P/E
25.6x
Revenue (TTM)
$2.66B
Div. yield
0.00%
Home Health and Senior Care Healthcare
3 wins

Head to Head

11 decided of 12

Koninklijke Philips leads on 6 of the 12 questions below (Koninklijke Philips 6, Chemed 3, Ensign 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionENSGPHGCHELeader
Larger companyMarket capitalisation $10.92B $29.42B $7.23B PHG
Cheaper on earningsLower P/E, profitable companies only 27.3x 15.4x 25.6x PHG
Cheaper on forward earningsLower price / next fiscal year consensus EPS 22.0x 14.4x 20.1x PHG
Faster revenue growthRevenue growth, trailing twelve months +17.5% +53.4% +5.2% PHG
More profitableNet margin, trailing twelve months 7.0% 6.3% 10.6% CHE
Better return on capitalReturn on invested capital 14.3% 12.4% 26.5% CHE
Less leveragedLower net debt / EBITDA -0.3x 1.4x 0.4x ENSG
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -0.9% +4.6% +21.0% CHE
Better 5-year returnAnnualised price return, 5 years +18.7%/yr -9.6%/yr +1.8%/yr ENSG
Less volatileAnnualised volatility, 1 year 29.4% 28.5% 29.0% PHG
Higher overall scoreMean of the five percentile scores vs peers 64/100 80/100 56/100 PHG

Percentile Scorecard

ENSGPHGCHE

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisENSGPHGCHE
Valuation 68 #31 of 95 98 #6 of 229 49 #49 of 95
Growth 61 #35 of 88 99 #4 of 221 13 #77 of 88
Profitability 73 #24 of 87 92 #17 of 209 93 #7 of 87
Financial Health 74 #27 of 100 36 #155 of 240 66 #35 of 100
Shareholder Returns 44 #33 of 58 78 #33 of 147 61 #23 of 58
Overall 64 80 56
  • ENSG ranked among 102 companies in Healthcare Providers
  • PHG ranked among 248 companies in Medical Devices and Diagnostics
  • CHE ranked among 102 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodENSGPHGCHESPY
1 month +6.1%+19.0%+5.1% -2.0%
3 months +3.5%+7.6%-1.1% -2.2%
6 months +3.6%+7.6%+24.7% +4.2%
Year to date +4.6%+5.1%+24.6% +10.6%
1 year -0.9%+4.6%+21.0% +10.4%
3 years +78.6%+38.5%-9.2% +73.6%
3 years, per year +21.4%+11.5%-3.2% +20.2%
5 years +135.5%-39.7%+9.4% +61.6%
5 years, per year +18.7%-9.6%+1.8% +10.1%
10 years +952.6%-2.8%+289.7% +261.3%
10 years, per year +26.5%-0.3%+14.6% +13.7%

Risk

MeasureENSGPHGCHESPY
Volatility, 1Y 29.4%28.5%29.0% 12.8%
Downside volatility, 1Y 25.2%27.8%32.2% 12.8%
Beta vs S&P 500, 1Y -0.030.80-0.01 1.00
Return / volatility, 1Y -0.030.160.72 0.81
Max drawdown, 5Y -31.8%-75.6%-43.4% -25.4%
From 52-week high -15.6%-13.5%-3.5% -3.2%
52-week high $215.83$32.91$552.43 $779.14
52-week low $147.13$23.81$368.59 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleENSGPHGCHE
P/E now vs peer median 26.4xmedian 24.9x 14.2xmedian 28.1x 24.9xmedian 24.9x
P/S now vs peer median 1.9xmedian 1.6x 0.9xmedian 2.9x 2.6xmedian 1.6x
EV/EBITDA now vs peer median 16.5xmedian 15.2x 7.9xmedian 18.0x 16.2xmedian 15.2x
P/FCF now vs peer median 20.9xmedian 20.7x 5.2xmedian 24.8x 23.5xmedian 20.7x
P/B now vs peer median 4.1xmedian 3.2x 2.1xmedian 2.3x 8.1xmedian 3.2x
PEG now vs peer median 1.67median 0.72 0.20median 0.95 2.50median 0.72

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsENSGPHGCHE
Revenue $5.67B $30.13B $2.66B
Gross profit $1.20B $16.13B $892.52M
Operating income $509.16M $2.79B $370.86M
Net income $399.32M $1.45B $282.40M
Free cash flow $509.91M $5.23B $295.45M
R&D – $1.99B –
EPS (diluted) $6.73 $1.98 $21.40
Cash & equivalents $337.59M $3.12B $48.43M
Total debt $198.72M $9.23B $236.00M
Shares (diluted) 59.30M 962.50M 13.20M
Enterprise value $9.04B $17.69B $7.05B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricENSGPHGCHE
P/E 26.4x 14.2x 24.9x
P/FCF 20.9x 5.2x 23.5x
P/Operating cash flow 15.3x 7.7x 19.1x
P/S 1.9x 0.9x 2.6x
P/B 4.1x 2.1x 8.1x
P/Tangible book 4.2x 2.7x 8.9x
EV/EBITDA 16.5x 7.9x 16.2x
EV/EBIT 20.5x 12.0x 19.2x
EV/Revenue 1.8x 1.1x 2.7x
EV/FCF 20.5x 6.4x 24.1x
EV/Operating cash flow 15.0x 9.4x 19.6x
PEG (3Y EPS CAGR) 1.67 0.20 2.50

Growth

14 metrics
MetricENSGPHGCHE
Revenue growth (1Y) 17.5% 53.4% 5.2%
Revenue CAGR (3Y) 16.8% 15.1% 6.1%
Gross profit growth (1Y) 21.7% 76.3% 6.9%
Gross profit CAGR (3Y) 16.3% 4.0% 5.1%
Operating income growth (1Y) 26.6% 49.6% 5.5%
Operating income CAGR (3Y) 18.3% 337.8% 6.1%
Net income growth (1Y) 21.6% 444.3% 1.3%
Net income CAGR (3Y) 17.2% 45.2% 4.9%
EPS growth (1Y) 20.9% 177.7% 10.6%
EPS CAGR (3Y) 15.9% 69.9% 10.0%
Operating cash flow growth (1Y) 44.5% 154.0% -13.5%
Operating cash flow CAGR (3Y) 26.8% 34.9% 4.1%
Free cash flow growth (1Y) 76.1% 74.5% -18.0%
Free cash flow CAGR (3Y) 29.2% 35.7% 4.5%

Profitability

14 metrics
MetricENSGPHGCHE
Gross margin 21.2% 53.5% 33.5%
EBITDA margin 11.1% 14.1% 16.5%
Operating margin 9.0% 9.2% 13.9%
Pretax margin 9.4% 8.7% 14.4%
Net margin 7.0% 6.3% 10.6%
FCF margin 9.0% 17.4% 11.1%
Operating cash flow margin 12.3% 11.8% 13.6%
Return on equity 16.0% 13.2% 33.4%
Return on assets 6.8% 5.5% 17.1%
Return on invested capital 14.3% 12.4% 26.5%
Return on capital employed 10.4% 12.6% 28.1%
Asset turnover 1.0x 1.0x 1.6x
Cash conversion (OCF / net income) 1.7x 2.4x 1.3x
Stock comp / revenue 1.1% 0.5% 1.2%

Financial Health

11 metrics
MetricENSGPHGCHE
Debt / assets 3.3% 29.0% 13.7%
Debt / equity 0.1x 0.7x 0.3x
Net debt / EBITDA -0.3x 1.4x 0.4x
Debt / FCF 0.4x 1.8x 0.8x
Liabilities / assets 57.3% 58.7% 49.9%
Equity / assets 42.7% 41.3% 50.1%
Interest coverage 62.8x 6.5x 75.4x
Current ratio 1.2x 1.3x 1.1x
Quick ratio 1.1x 0.8x 0.9x
Cash ratio 0.4x 0.4x 0.1x
Altman Z-score 3.60 – 9.70

Shareholder Returns

7 metrics
MetricENSGPHGCHE
Dividend yield 0.2% 3.5% 0.5%
Net buyback yield 0.2% -0.8% 7.1%
Shareholder yield 0.3% 2.7% 7.6%
Payout ratio (earnings) – – 11.9%
Payout ratio (FCF) – – 11.4%
Dividend growth (1Y) – – 9.9%
Dividend CAGR (3Y) – – 13.5%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusENSGPHGCHE
Forward P/E 22.0xFY2026 14.4xFY2026 20.1xFY2026
EPS, next fiscal year $8.29FY2026 $1.98FY2026 $26.52FY2026
EPS growth, next FY +26.2%FY2026 +6.5%FY2026 +23.1%FY2026
EPS growth, the year after -1.8% -10.1% +8.0%
Revenue, next fiscal year $5.76BFY2026 $21.63BFY2026 $2.66BFY2026
Revenue growth, next FY +13.9%FY2026 +1.8%FY2026 +5.1%FY2026
Revenue growth, the year after +16.9% -8.2% +15.2%
ENSG estimates →PHG estimates →CHE estimates →

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersENSGPHGCHE
Held by institutions 89.8% 5.4% 100.0%
Institutions holding 549 365 528
Change in shares held, QoQ -1.2% +0.8% +2.8%
Institutions buying 250 268 276
Institutions selling 215 76 187
Buyers to sellers 1.16 3.53 1.48
ENSG holders →PHG holders →CHE holders →

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ENSGPHGCHE
ENSG 1.00 0.17 0.38
PHG 0.17 1.00 0.08
CHE 0.38 0.08 1.00

Add a Peer

Largest companies in the same industry
ENSG · Home Health and Senior Care
+BTSGBrightSpring Health Services +PACSPacs +OPCHOption Care Health +NHCNational Healthcare +AVAHAveanna Healthcare Holdings +BKDBrookdale Senior Living +ADUSAddus HomeCare +SNDASonida Senior Living
Plot all 26 Home Health and Senior Care stocks → Plot all 112 Diagnostic Equipment stocks →

Related Comparisons

ENSG vs BTSGBrightSpring Health Services ENSG vs PACSPacs ENSG vs OPCHOption Care Health ENSG vs NHCNational Healthcare

Frequently Asked Questions

Which is bigger, ENSG, PHG and CHE?

Koninklijke Philips (PHG) is the largest by market capitalisation: Ensign (ENSG) $10.92B, Koninklijke Philips (PHG) $29.42B, Chemed (CHE) $7.23B.

Which stock is cheaper, ENSG, PHG and CHE?

Koninklijke Philips (PHG) trades on the lowest price-to-earnings ratio (Ensign (ENSG) 27.3x, Koninklijke Philips (PHG) 15.4x, Chemed (CHE) 25.6x). On next year's consensus earnings, Koninklijke Philips (PHG) is cheapest (Ensign (ENSG) 22.0x, Koninklijke Philips (PHG) 14.4x, Chemed (CHE) 20.1x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Koninklijke Philips (PHG) grew revenue fastest over the trailing twelve months: Ensign (ENSG) +17.5%, Koninklijke Philips (PHG) +53.4%, Chemed (CHE) +5.2%.

Which company is more profitable?

Chemed (CHE) has the highest net margin (Ensign (ENSG) 7.0%, Koninklijke Philips (PHG) 6.3%, Chemed (CHE) 10.6%). On return on invested capital, Chemed (CHE) leads (Ensign (ENSG) 14.3%, Koninklijke Philips (PHG) 12.4%, Chemed (CHE) 26.5%).

Which stock has performed better?

Over the past year Chemed (CHE) returned the most: Ensign (ENSG) -0.9%, Koninklijke Philips (PHG) +4.6%, Chemed (CHE) +21.0%. Over five years, Ensign (ENSG) compounded fastest (Ensign (ENSG) +18.7%/yr, Koninklijke Philips (PHG) -9.6%/yr, Chemed (CHE) +1.8%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Ensign (ENSG) 0.00%, Koninklijke Philips (PHG) 0.00%, Chemed (CHE) 0.00%. Ensign (ENSG) and Koninklijke Philips (PHG) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Koninklijke Philips (PHG) has been the steadiest (Ensign (ENSG) 29.4%, Koninklijke Philips (PHG) 28.5%, Chemed (CHE) 29.0%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ENSG, PHG and CHE?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Koninklijke Philips (PHG) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.